Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of 8.56 billion as of May 23, 2025. Its market cap has increased by 90.01% in one year.

Market Cap

8.56B

Enterprise Value

7.09B

Revenue

681.16M

Ranking

n/a

PE Ratio

49.20

Stock Price

8.90

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 8.56B, a decrease of -29.30%. That is a compound annual growth rate of -6.16%.

Market Cap History

Date	Market Cap	% Change
May 23, 2025	8.56B	154.18%
Dec 31, 2024	3.37B	-47.42%
Dec 29, 2023	6.41B	-36.87%
Dec 30, 2022	10.15B	-20.36%
Dec 31, 2021	12.74B	-16.28%
Dec 31, 2020	15.22B	21.20%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	200.29B
Hansoh Pharmaceutical Group Company	152.81B
JD Health International	132.72B
WuXi Biologics	100.38B
Innovent Biologics	92.21B
Akeso	78.90B
Alibaba Health Information Technology	77.68B
Sichuan Kelun-Biotech Biopharmaceutical	74.98B

Market Cap Rankings